Transplantation of Neural Stem Cells Modified by Human Neurotrophin-3 Promotes Functional Recovery after Transient Focal Cerebral Ischemia in Rats

Zi-heng Zhang,Ren-zhi Wang,Gui-lin Li,Jun-ji Wei,Zhao-jian Li,Ming Feng,Jun Kang,Wan-chen Du,Wen-bin Ma,Yong-ning Li,Yi Yang,Yan-guo Kong
DOI: https://doi.org/10.1016/j.neulet.2008.08.049
IF: 3.197
2008-01-01
Neuroscience Letters
Abstract:The study tested the hypothesis that transplantation of human neurotrophin-3 (hNT-3) over-expressing neural stem cells (NSCs) into rat striatum after a severe focal ischemia would promote functional recovery. Rat NSCs, transduced by Flag-tagged hNT-3 gene mediated by lentiviral vector (LV), were transplanted into the striatum ipsilateral to the injury of adult rats 7 days after 2-h occlusion of the middle cerebral artery (MCAO). From 3 days to 2 weeks after transplantation, the modified cells (NSCs-hNT3, as defined by Flag immunofluorencence staining) that survived the transplantation procedures could secrete significantly higher levels of neurotrophin-3 protein in the graft sites than controls (P<0.001). Furthermore, the rats that accepted NSCs-hNT3 exhibited enhanced functional recovery on neurological and behavioral tests, compared with controlled animals transplanted with saline or untransduced NSCs. This study suggests: (1) LV is an ideal vector to transduce foreign gene into the NSCs; (2) modified NSCs could carry therapeutic genes to disease tissues and express effectively; (3) modified cells could survive in the ischemic brains and continue to secrete neurotrophin-3 abundantly for over 2 weeks, which might have values for enhancing functional recovery after stroke.
What problem does this paper attempt to address?